View Grant Opportunity
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
National Institutes of Health
PAR-25-106
HHS-NIH11
General Information
N/a
Est. Program Funding:
Est. Program Funding:
May 4, 2026
Closing Date:
Closing Date:
N/a
Expected No. of Awards
Expected No. of Awards
$475,000
Award Ceiling
Award Ceiling
Opportunity Number:
PAR-25-106
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. The clinical translation of these interventions is outside of the scope of this NOFO. | |
| Response Date | May 04, 2026 12:00:00 AM EDT |
| Posting Date | Nov 21, 2024 12:00:00 AM EST |
| Archive Date | Jun 09, 2026 12:00:00 AM EDT |
| Award Ceiling | 475,000 |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | Small businesses, Native American tribal governments (Federally recognized), Special district governments, Public and State controlled institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, City or township governments, Private institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Public housing authorities/Indian housing authorities, Independent school districts, County governments, State governments, For profit organizations other than small businesses |
| Additional Info on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-106.html |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.394: Cancer Detection and Diagnosis Research
- 93.395: Cancer Treatment Research
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.